Subscribe To
Novavax shares gain over 29% after $350 million vaccine deal with canada
Shares of Novavax soared over 29% after the Canadian government agreed to pay the biotech firm almost $...
July 10, 2023, 5:10 pm
Viridian stock falls more than 15% after drug study update
Shares of Viridian Therapeutics Inc. VRDN, +5.06% fell in the extended session Monday after the biotech ...
July 10, 2023, 4:55 pm
Why is novavax (nvax) up 30% today?
Embattled biotechnology firm Novavax (NASDAQ: NVAX ) — which previously incurred serious business viability risks — received much-needed positive ...
July 10, 2023, 1:37 pm
Nanobiotix surges on commercialization deal with j&j's janssen for cancer therapeutic
French biotechnology company Nanobiotix has entered into an agreement with J&J's wholly-owned medical research and pharmaceutical arm Janssen to licen...
July 10, 2023, 1:11 pm
biotech stock pops on reaction to experimental therapy
Iovance Biotherapeutics Inc (NASDAQ:IOVA) was last seen up 2.4% at $7.42, after the U.S. Food and Drug Administration (FDA) said a late-stage study o...
July 10, 2023, 10:22 am
Apogee therapeutics sets ipo terms, to be valued at up to $774.5 mln
Apogee Therapeutics Inc. APGE, has set terms for its initial public offering, as the Massachusetts-based biotechnology company developing treatments f...
July 10, 2023, 6:28 am
Nanobiotix's stock soars after entering licensing, development deal with j&j's janssen pharmaceutica
Shares of Nanobiotix SA NBTX, +1.57% shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company an...
July 10, 2023, 6:14 am
Mirum: must watch biotech on release of results from embark study
Results from the phase 2b EMBARK study, which is using LIMVARLI for the treatment of patients with biliary atresia, are expected in the 2nd half of 20...
July 9, 2023, 11:01 am
Sana biotechnology: hypoimmune platform might stealth cells
Results from the phase 1 study using SC291 for the treatment of patients with B-cell lymphomas are expected to be released later in 2023. It is said t...
July 9, 2023, 10:09 am
Replimune: the rise of oncolytic virus therapies in cancer treatment
The company's RPx platform, featuring RP1, RP2, and RP3, showcases a comprehensive and innovative approach to cancer treatment. Top-line results from ...
July 9, 2023, 1:22 am
Looking for biotech ai stocks? 3 names that will benefit from the ai boom
AI is coming to biotech in a big way. From protein folding to drug screening, from studying cells to st...
July 8, 2023, 8:43 pm
Adaptive biotechnologies: getting closer to the 'buy zone'
Shares of diagnostics and drug discovery concern Adaptive Biotechnologies Corporation have crashed over 90% as the commercial-stage concern struggles ...
July 7, 2023, 2:00 pm
Pfizer just invested $25 million in this biotech
Shares of Caribou Biosciences NASDAQ: CRBU were up 45% yesterday after Pfizer NYSE: PFE made a $25 million equity investment. On Thursday, the company...
July 7, 2023, 9:59 am
Why bioxcel therapeutics stock was bouncing back this week
The biotech was in the running for Comeback Stock of the Week. It had tanked significantly after publis...
July 7, 2023, 8:16 am
3 biotech stocks to make your ‘get rich' dreams come true
Navigating the choppy waters in the biotech sphere can be daunting, which makes it a challenge to hunt ...
July 6, 2023, 4:43 pm
Why shares of caribou biosciences are skyrocketing today
Caribou is a clinical-stage biotech that specializes in CRISPR gene-editing therapies. Caribou said it ...
July 6, 2023, 11:54 am
Thermo fisher scientific to acquire data intelligence provider corevitas
Thermo Fisher Scientific (NYSE:TMO) Inc on Thursday announced it would acquire data intelligence company CorEvitas from Audax Private Equity for $912....
July 6, 2023, 10:27 am
3 biotech stocks that ai predicts will deliver triple-digit returns in 2025
Investing in the biotech sector is mostly about risk and reward. When a company achieves FDA approval o...
July 5, 2023, 8:24 pm
Immunitybio, inc. (ibrx) shareholder notice: robbins llp reminds investors of class action against immunitybio, inc.
SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entit...
July 5, 2023, 4:19 pm
The 3 best biotech stocks to buy in july
Although it's been a difficult year for biotechnology stocks, there are still plenty of reasons for investors to be bullish on the sector. Many of the...
July 5, 2023, 1:05 pm